CalciMedica, Inc. CALC
1.47 USD +0.07 (+5.00%)
Nov 3, 2026, 3:59 PM EST
1.38 Day range 1.53
1.00 52-week range 36.00
- YTD
- -95.54%
- 1 year
- -90.17%
Analyst view
Price target (mean) 17.00 +1056.5% upside
Now 1.47
- Target (low)
- 15.00
- Target (mean)
- 17.00
- Target (high)
- 20.00
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | LUCID CAPITAL MARKETS | Initiated | — | Buy |
| Nov 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 4, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 10, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 27, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 1, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 16, 2024 | JonesTrading | Initiated | — | Buy |
| Feb 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 29, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 13, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jul 7, 2023 | EF Hutton | Reiterated | Buy | Buy |
| Jun 20, 2023 | EF Hutton | Initiated | — | Buy |
| May 16, 2023 | Oppenheimer | Reiterated | — | Outperform |
| Mar 24, 2023 | Oppenheimer | Initiated | — | Outperform |
